Paul Shin

708 total citations
18 papers, 543 citations indexed

About

Paul Shin is a scholar working on Psychiatry and Mental health, Molecular Biology and Speech and Hearing. According to data from OpenAlex, Paul Shin has authored 18 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 3 papers in Molecular Biology and 3 papers in Speech and Hearing. Recurrent topics in Paul Shin's work include Epilepsy research and treatment (4 papers), Dementia and Cognitive Impairment Research (4 papers) and Dysphagia Assessment and Management (3 papers). Paul Shin is often cited by papers focused on Epilepsy research and treatment (4 papers), Dementia and Cognitive Impairment Research (4 papers) and Dysphagia Assessment and Management (3 papers). Paul Shin collaborates with scholars based in United States, Germany and United Kingdom. Paul Shin's co-authors include Harry H. Mansbach, Virinder Nohria, Susan T. Hall, João Siffert, Bassel Abou‐Khalil, Elza Márcia Targas Yacubian, Robert Leroy, Jacqueline A. French, Martin J. Brodie and Christian E. Elger and has published in prestigious journals such as JAMA, Gastroenterology and Neurology.

In The Last Decade

Paul Shin

18 papers receiving 524 citations

Peers

Paul Shin
Thomas Stoehr United States
Joseph Stringfellow United States
Markéta Marvanová United States
Gary W. Jay United States
Michele C. Meyer United States
Boris Finkel Israel
Alma Mihaljević Peleš Croatia
Patrick Imfeld Switzerland
Joseph D’Souza United States
Heidi N. Boyda Canada
Thomas Stoehr United States
Paul Shin
Citations per year, relative to Paul Shin Paul Shin (= 1×) peers Thomas Stoehr

Countries citing papers authored by Paul Shin

Since Specialization
Citations

This map shows the geographic impact of Paul Shin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Shin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Shin more than expected).

Fields of papers citing papers by Paul Shin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Shin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Shin. The network helps show where Paul Shin may publish in the future.

Co-authorship network of co-authors of Paul Shin

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Shin. A scholar is included among the top collaborators of Paul Shin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Shin. Paul Shin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
D’Amico, Stephen, David N. Alexander, Andrew J. Cutler, et al.. (2017). Safety and Tolerability of Dextromethorphan/Quinidine in Older Patients. American Journal of Geriatric Psychiatry. 25(3). S142–S142. 2 indexed citations
2.
3.
Hammond, Flora M., David N. Alexander, Andrew J. Cutler, et al.. (2016). PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury. BMC Neurology. 16(1). 160–160. 27 indexed citations
4.
5.
Cummings, Jeffrey L., Constantine G. Lyketsos, Pierre N. Tariot, et al.. (2015). Dextromethorphan/Quinidine (AVP-923) Efficacy and Safety for Treatment of Agitation in Persons With Alzheimer’s Disease: Results From a Phase 2 Study (NCT01584440) (S16.007). Neurology. 84(14_supplement). 4 indexed citations
6.
Cummings, Jeffrey L., Constantine G. Lyketsos, Elaine R. Peskind, et al.. (2015). Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia. JAMA. 314(12). 1242–1242. 131 indexed citations
7.
Cummings, Jeffrey L., Constantine G. Lyketsos, Pierre N. Tariot, et al.. (2015). Dextromethorphan/quinidine (AVP-923) Efficacy and Safety for Treatment of Agitation in Persons with Alzheimer's Disease: Results from a Phase 2 Study (NCT01584440). American Journal of Geriatric Psychiatry. 23(3). S164–S165. 7 indexed citations
8.
9.
Doody, Rachelle S., Stephen D’Amico, Andrew J. Cutler, et al.. (2015). An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in dementia: PRISM II results. CNS Spectrums. 21(6). 450–459. 10 indexed citations
10.
11.
Zorowitz, Richard D., et al.. (2015). Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect in Patients with Stroke: PRISM-II. Archives of Physical Medicine and Rehabilitation. 96(10). e53–e53. 1 indexed citations
12.
Hammond, Flora M., et al.. (2015). Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect in Patients with Traumatic Brain Injury: PRISM-II.. Archives of Physical Medicine and Rehabilitation. 96(10). e4–e5. 1 indexed citations
13.
14.
15.
Shin, Paul, et al.. (2012). Evaluation of treatment continuation with alosetron by IBS-D severity criteria. Current Medical Research and Opinion. 28(3). 449–456. 6 indexed citations
16.
French, Jacqueline A., Bassel Abou‐Khalil, Robert Leroy, et al.. (2011). Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy. Neurology. 76(18). 1555–1563. 149 indexed citations
17.
Brodie, Martin J., Holger Lerche, António Gil‐Nagel, et al.. (2010). Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy. Neurology. 75(20). 1817–1824. 153 indexed citations
18.
Shin, Paul, et al.. (2010). M1058 Alosetron is Associated With Improvements in Treatment Satisfaction and Quality of Life. Gastroenterology. 138(5). S–322. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Stoehr Breakdown of academic impact, for papers by Joseph Stringfellow Breakdown of academic impact, for papers by Markéta Marvanová Breakdown of academic impact, for papers by Gary W. Jay Breakdown of academic impact, for papers by Michele C. Meyer Breakdown of academic impact, for papers by Boris Finkel Breakdown of academic impact, for papers by Alma Mihaljević Peleš Breakdown of academic impact, for papers by Patrick Imfeld Breakdown of academic impact, for papers by Joseph D’Souza Breakdown of academic impact, for papers by Heidi N. Boyda
Rankless by CCL
2026